0001209191-20-016786.txt : 20200305 0001209191-20-016786.hdr.sgml : 20200305 20200305193207 ACCESSION NUMBER: 0001209191-20-016786 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200304 FILED AS OF DATE: 20200305 DATE AS OF CHANGE: 20200305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Manning Daniel E. CENTRAL INDEX KEY: 0001741456 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38525 FILM NUMBER: 20692236 MAIL ADDRESS: STREET 1: 255 SOUTH KING ST., SUITE 1800 CITY: SEATTLE STATE: WA ZIP: 98104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVALARA, INC. CENTRAL INDEX KEY: 0001348036 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 911995935 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 255 S. KING ST. STREET 2: SUITE 1800 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: (206) 826-4900 MAIL ADDRESS: STREET 1: 255 S. KING ST. STREET 2: SUITE 1800 CITY: SEATTLE STATE: WA ZIP: 98104 FORMER COMPANY: FORMER CONFORMED NAME: AVALARA INC DATE OF NAME CHANGE: 20051227 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-04 0 0001348036 AVALARA, INC. AVLR 0001741456 Manning Daniel E. 255 SOUTH KING ST. SUITE 1800 SEATTLE WA 98104 0 1 0 0 Chief Accounting Officer Common Stock 2020-03-04 4 M 0 6248 13.76 A 13249 D Common Stock 2020-03-04 4 M 0 6701 16.60 A 19950 D Common Stock 2020-03-04 4 S 0 9985 83.29 D 9965 D Common Stock 2020-03-04 4 S 0 2964 84.09 D 7001 D Stock Option (right to buy) 13.76 2020-03-04 4 M 0 6248 0.00 D 2026-12-13 Common Stock 6248 4692 D Stock Option (right to buy) 16.60 2020-03-04 4 M 0 6701 0.00 D 2028-01-23 Common Stock 6701 12285 D The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.95 to $83.88 inclusive. Upon request by Avalara, Inc., any security holder thereof, or the staff of the Securities and Exchange Commission, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.01 to $84.15, inclusive. The option vested and became exercisable as to 25% of the total shares on November 30, 2017, and 1/48th of the total shares vest and become exercisable monthly thereafter such that the option is fully vested and exercisable on November 30, 2020. The option vested and became exercisable as to 25% of the total shares on January 1, 2019, and 1/48th of the total shares vest and become exercisable monthly thereafter such that the option is fully vested and exercisable on January 1, 2022. /s/ Alesia L. Pinney, Attorney-in-Fact 2020-03-05